<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02604550</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00083740</org_study_id>
    <nct_id>NCT02604550</nct_id>
  </id_info>
  <brief_title>Anterior Cruciate Ligament Pain Study</brief_title>
  <official_title>Comparison Between Femoral Nerve Block and Adductor Canal Block for Anterior Cruciate Ligament Reconstruction: A Prospective Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Emory University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Emory University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to compare the pain control benefit of two different types of
      nerve blocks in patients undergoing anterior cruciate ligament (ACL) reconstruction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This trial is a prospective, randomized, surgeon-blinded, two-armed trial to investigate the
      safety and efficacy of femoral nerve blocks versus adductor canal blocks for participants
      undergoing outpatient anterior cruciate ligament (ACL) reconstruction surgery.

      The objective of this study is to compare the pain control benefit of two different types of
      nerve blocks. Ropivacaine, which is FDA-approved for use in both femoral nerve blocks as well
      as adductor canal blocks, will be utilized. The study will be comparing the efficacy between
      FDA approved treatments.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Score</measure>
    <time_frame>Post-surgery (day of surgery to 6 days post-surgery)</time_frame>
    <description>Pain scores range from 0 (no pain at all) to 10 (worst imaginable pain). Pain level was reported at the time of discharge from the surgery recovery room, the evening of the day of surgery, and then three times per day for six days post-surgery. During the six days after surgery, the morning assessment asked about typical knee pain levels overnight, the afternoon assessment asked about knee pain levels since the morning entry, and the evening assessment asked about knee pain levels since the afternoon entry.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Percocet Tablets Consumed</measure>
    <time_frame>Post surgery, Day 0 to Day 6</time_frame>
    <description>Participants recorded the total number of Percocet 7.5/325 (acetaminophen and oxycodone) tablets they took every day, in order to assess post-surgical use of opioids between the study arms,</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Hours of Sleep</measure>
    <time_frame>First Postoperative Night (up to 12 hours)</time_frame>
    <description>The total hours of sleep first postoperative night, between 0 to 12 hours.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient-Reported Nausea</measure>
    <time_frame>Post-Surgery (up to 6 days)</time_frame>
    <description>Total occurrences of patient-reported nausea post-surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient-Reported Vomiting</measure>
    <time_frame>Post-Surgery (up to 6 days)</time_frame>
    <description>Total occurrences of patient-reported vomiting post-surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient-Reported Constipation</measure>
    <time_frame>Post-Surgery (up to 6 days)</time_frame>
    <description>Total occurrences of patient-reported constipation post-surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient-Reported Sedation</measure>
    <time_frame>Post-Surgery (up to 6 days)</time_frame>
    <description>Total occurrences of patient-reported feelings of sedation post-surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient-Reported Itching</measure>
    <time_frame>Post-Surgery (up to 6 days)</time_frame>
    <description>Total occurrences of patient-reported itching post-surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Straight Less Raise</measure>
    <time_frame>Post-Surgery (up to 6 days)</time_frame>
    <description>The amount of time (in hours) it takes for participants to have the ability to perform a straight leg raise post-surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent of Patients Rating Their Satisfaction as &quot;Excellent&quot; or &quot;Good&quot;</measure>
    <time_frame>2 Weeks Post-Surgery</time_frame>
    <description>Patient satisfaction will be reported on a scale of excellent, good, satisfactory, or poor, two weeks following surgery.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">115</enrollment>
  <condition>Anterior Cruciate Ligament Reconstruction</condition>
  <arm_group>
    <arm_group_label>Femoral Nerve Block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects undergoing anterior cruciate ligament (ACL) surgery will be randomized to receive 20 mL of ropivacaine 0.5% in the femoral nerve. Subjects will also receive standard of care Percocet 7.5/325 and naprosyn following surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Adductor Canal Block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects undergoing anterior cruciate ligament surgery will be randomized to receive 20 mL of ropivacaine 0.5% in the adductor canal. Subjects will also receive standard of care Percocet 7.5/325 and naprosyn following surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine 0.5%</intervention_name>
    <description>Ropivacaine 0.5% will be administered to the femoral nerve or adductor canal.</description>
    <arm_group_label>Femoral Nerve Block</arm_group_label>
    <arm_group_label>Adductor Canal Block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Percocet 7.5/325</intervention_name>
    <description>Percocet 7.5/325 will taken as needed up to every four hours.</description>
    <arm_group_label>Femoral Nerve Block</arm_group_label>
    <arm_group_label>Adductor Canal Block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Naprosyn 500 mg</intervention_name>
    <description>Naprosyn 500 mg will be taken twice daily.</description>
    <arm_group_label>Femoral Nerve Block</arm_group_label>
    <arm_group_label>Adductor Canal Block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing scheduled anterior cruciate ligament (ACL) surgery at the Emory
             Orthopaedic and Spine Center

          -  Patients willing and able to provide written informed consent

          -  Parents willing and able to provide written informed consent for minors

        Exclusion Criteria:

          -  Patients who are pregnant or lactating

          -  Patients with liver dysfunction or renal failure

          -  Patients with a known allergy to ropivacaine

          -  Patients with a local infection

          -  Patients who take chronic pain medications

          -  Patients with an opioid tolerance

          -  Patients with known coagulopathy or bleeding risk.

          -  Patients who are getting neuraxial anesthesia for surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John Xerogeanes, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Emory University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Emory Healthcare Orthopaedics and Spine Center</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30329</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 11, 2015</study_first_submitted>
  <study_first_submitted_qc>November 11, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 13, 2015</study_first_posted>
  <results_first_submitted>April 21, 2017</results_first_submitted>
  <results_first_submitted_qc>April 21, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">May 31, 2017</results_first_posted>
  <last_update_submitted>April 21, 2017</last_update_submitted>
  <last_update_submitted_qc>April 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Emory University</investigator_affiliation>
    <investigator_full_name>John Xerogeanes</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Acetaminophen, hydrocodone drug combination</mesh_term>
    <mesh_term>Oxycodone</mesh_term>
    <mesh_term>Naproxen</mesh_term>
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Patients undergoing scheduled anterior cruciate ligament (ACL) surgery at the Emory Orthopaedic and Spine Center in Atlanta, Georgia were prospectively randomized to receive either a femoral nerve block (FNB) or an adductor canal block (ACB). Participants were enrolled between December 2015 and April 2016.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Femoral Nerve Block</title>
          <description>Participants randomized to receive 20 milliliter (mL) of ropivacaine 0.5% in the femoral nerve.</description>
        </group>
        <group group_id="P2">
          <title>Adductor Canal Block</title>
          <description>Participants randomized to receive 20 milliliter (mL) of ropivacaine 0.5% in the adductor canal</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="56"/>
                <participants group_id="P2" count="59"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="31"/>
                <participants group_id="P2" count="33"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="26"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Incomplete data using paper journal</title>
              <participants_list>
                <participants group_id="P1" count="18"/>
                <participants group_id="P2" count="19"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>All participants who consented to take part in the trial and received the intervention of the study arm they were randomized to.</population>
      <group_list>
        <group group_id="B1">
          <title>Femoral Nerve Block</title>
          <description>Participants randomized to receive 20mL of ropivacaine 0.5% in the femoral nerve.</description>
        </group>
        <group group_id="B2">
          <title>Adductor Canal Block</title>
          <description>Participants randomized to receive 20mL of ropivacaine 0.5% in the adductor canal</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="56"/>
            <count group_id="B2" value="59"/>
            <count group_id="B3" value="115"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="31"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                    <measurement group_id="B2" value="42"/>
                    <measurement group_id="B3" value="84"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="64"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="43"/>
                    <measurement group_id="B2" value="35"/>
                    <measurement group_id="B3" value="78"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="28"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="47"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56"/>
                    <measurement group_id="B2" value="59"/>
                    <measurement group_id="B3" value="115"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Pain Score</title>
        <description>Pain scores range from 0 (no pain at all) to 10 (worst imaginable pain). Pain level was reported at the time of discharge from the surgery recovery room, the evening of the day of surgery, and then three times per day for six days post-surgery. During the six days after surgery, the morning assessment asked about typical knee pain levels overnight, the afternoon assessment asked about knee pain levels since the morning entry, and the evening assessment asked about knee pain levels since the afternoon entry.</description>
        <time_frame>Post-surgery (day of surgery to 6 days post-surgery)</time_frame>
        <population>This analysis includes participants who completed the study and used a smartphone application to record pain level for 6 days post-surgery.</population>
        <group_list>
          <group group_id="O1">
            <title>Femoral Nerve Block</title>
            <description>Participants randomized to receive 20mL of ropivacaine 0.5% in the femoral nerve.</description>
          </group>
          <group group_id="O2">
            <title>Adductor Canal Block</title>
            <description>Participants randomized to receive 20mL of ropivacaine 0.5% in the adductor canal</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Score</title>
          <description>Pain scores range from 0 (no pain at all) to 10 (worst imaginable pain). Pain level was reported at the time of discharge from the surgery recovery room, the evening of the day of surgery, and then three times per day for six days post-surgery. During the six days after surgery, the morning assessment asked about typical knee pain levels overnight, the afternoon assessment asked about knee pain levels since the morning entry, and the evening assessment asked about knee pain levels since the afternoon entry.</description>
          <population>This analysis includes participants who completed the study and used a smartphone application to record pain level for 6 days post-surgery.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Recovery room discharge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.1" spread="1.8"/>
                    <measurement group_id="O2" value="4.0" spread="2.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day of surgery, evening</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.9" spread="2.2"/>
                    <measurement group_id="O2" value="5.1" spread="2.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-surgery Day 1 - Morning</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.7" spread="2.6"/>
                    <measurement group_id="O2" value="5.7" spread="2.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-surgery Day 1 - Afternoon</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.1" spread="2.3"/>
                    <measurement group_id="O2" value="5.0" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-surgery Day 1 - Evening</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.5" spread="2.3"/>
                    <measurement group_id="O2" value="6.0" spread="2.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-surgery Day 2 - Morning</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.4" spread="2.3"/>
                    <measurement group_id="O2" value="5.3" spread="2.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-surgery Day 2 - Afternoon</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.5" spread="1.9"/>
                    <measurement group_id="O2" value="4.6" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-surgery Day 2 - Evening</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.3" spread="2.0"/>
                    <measurement group_id="O2" value="4.5" spread="2.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-surgery Day 3 - Morning</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.2" spread="2.0"/>
                    <measurement group_id="O2" value="4.0" spread="3.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-surgery Day 3 - Afternoon</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.8" spread="1.9"/>
                    <measurement group_id="O2" value="3.4" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-surgery Day 3 - Evening</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.0" spread="2.1"/>
                    <measurement group_id="O2" value="3.7" spread="2.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-surgery Day 4 - Morning</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.5" spread="2.2"/>
                    <measurement group_id="O2" value="3.0" spread="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-surgery Day 4 - Afternoon</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.2" spread="2.1"/>
                    <measurement group_id="O2" value="2.7" spread="2.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-surgery Day 4 - Evening</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.0" spread="2.4"/>
                    <measurement group_id="O2" value="3.3" spread="2.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-surgery Day 5 - Morning</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.7" spread="2.2"/>
                    <measurement group_id="O2" value="3.1" spread="2.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-surgery Day 5 - Afternoon</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.6" spread="2.1"/>
                    <measurement group_id="O2" value="3.3" spread="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-surgery Day 5 - Evening</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.4" spread="2.3"/>
                    <measurement group_id="O2" value="3.3" spread="2.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-surgery Day 6 - Morning</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.7" spread="2.2"/>
                    <measurement group_id="O2" value="3.1" spread="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-surgery Day 6 - Afternoon</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.2" spread="1.6"/>
                    <measurement group_id="O2" value="3.2" spread="2.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-surgery Day 6 - Evening</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.7" spread="1.6"/>
                    <measurement group_id="O2" value="2.8" spread="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Percocet Tablets Consumed</title>
        <description>Participants recorded the total number of Percocet 7.5/325 (acetaminophen and oxycodone) tablets they took every day, in order to assess post-surgical use of opioids between the study arms,</description>
        <time_frame>Post surgery, Day 0 to Day 6</time_frame>
        <population>This analysis includes participants who completed the study and used a smartphone application to record the number of Percocet tablets taken for 6 days post-surgery.</population>
        <group_list>
          <group group_id="O1">
            <title>Femoral Nerve Block</title>
            <description>Participants randomized to receive 20mL of ropivacaine 0.5% in the femoral nerve.</description>
          </group>
          <group group_id="O2">
            <title>Adductor Canal Block</title>
            <description>Participants randomized to receive 20mL of ropivacaine 0.5% in the adductor canal</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Percocet Tablets Consumed</title>
          <description>Participants recorded the total number of Percocet 7.5/325 (acetaminophen and oxycodone) tablets they took every day, in order to assess post-surgical use of opioids between the study arms,</description>
          <population>This analysis includes participants who completed the study and used a smartphone application to record the number of Percocet tablets taken for 6 days post-surgery.</population>
          <units>count of tablets</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day of surgery (Day 0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.0" spread="1.2"/>
                    <measurement group_id="O2" value="2.4" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-surgery Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.6" spread="2.5"/>
                    <measurement group_id="O2" value="4.7" spread="2.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-surgery Day 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.7" spread="2.6"/>
                    <measurement group_id="O2" value="3.6" spread="2.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-surgery Day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.3" spread="1.9"/>
                    <measurement group_id="O2" value="2.2" spread="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-surgery Day 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.1" spread="1.3"/>
                    <measurement group_id="O2" value="1.2" spread="2.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-surgery Day 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.6" spread="1.4"/>
                    <measurement group_id="O2" value="1.4" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-surgery Day 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3" spread="0.7"/>
                    <measurement group_id="O2" value="0.4" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Hours of Sleep</title>
        <description>The total hours of sleep first postoperative night, between 0 to 12 hours.</description>
        <time_frame>First Postoperative Night (up to 12 hours)</time_frame>
        <population>This analysis includes participants who completed the study and used a smartphone application to record their number of hours of sleep during the night following their surgery.</population>
        <group_list>
          <group group_id="O1">
            <title>Femoral Nerve Block</title>
            <description>Participants randomized to receive 20mL of ropivacaine 0.5% in the femoral nerve.</description>
          </group>
          <group group_id="O2">
            <title>Adductor Canal Block</title>
            <description>Participants randomized to receive 20mL of ropivacaine 0.5% in the adductor canal</description>
          </group>
        </group_list>
        <measure>
          <title>Total Hours of Sleep</title>
          <description>The total hours of sleep first postoperative night, between 0 to 12 hours.</description>
          <population>This analysis includes participants who completed the study and used a smartphone application to record their number of hours of sleep during the night following their surgery.</population>
          <units>hours</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.3" spread="2.0"/>
                    <measurement group_id="O2" value="5.8" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient-Reported Nausea</title>
        <description>Total occurrences of patient-reported nausea post-surgery.</description>
        <time_frame>Post-Surgery (up to 6 days)</time_frame>
        <population>This analysis includes participants completing the study who used a smartphone application for 6 days post-operatively to record every time they experienced nausea.</population>
        <group_list>
          <group group_id="O1">
            <title>Femoral Nerve Block</title>
            <description>Participants randomized to receive 20mL of ropivacaine 0.5% in the femoral nerve.</description>
          </group>
          <group group_id="O2">
            <title>Adductor Canal Block</title>
            <description>Participants randomized to receive 20mL of ropivacaine 0.5% in the adductor canal</description>
          </group>
        </group_list>
        <measure>
          <title>Patient-Reported Nausea</title>
          <description>Total occurrences of patient-reported nausea post-surgery.</description>
          <population>This analysis includes participants completing the study who used a smartphone application for 6 days post-operatively to record every time they experienced nausea.</population>
          <units>occurrence of nausea</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient-Reported Vomiting</title>
        <description>Total occurrences of patient-reported vomiting post-surgery.</description>
        <time_frame>Post-Surgery (up to 6 days)</time_frame>
        <population>This analysis includes participants who completed the study and used a smartphone application for 6 days post-operatively to record every time they experienced vomiting.</population>
        <group_list>
          <group group_id="O1">
            <title>Femoral Nerve Block</title>
            <description>Participants randomized to receive 20mL of ropivacaine 0.5% in the femoral nerve.</description>
          </group>
          <group group_id="O2">
            <title>Adductor Canal Block</title>
            <description>Participants randomized to receive 20mL of ropivacaine 0.5% in the adductor canal</description>
          </group>
        </group_list>
        <measure>
          <title>Patient-Reported Vomiting</title>
          <description>Total occurrences of patient-reported vomiting post-surgery.</description>
          <population>This analysis includes participants who completed the study and used a smartphone application for 6 days post-operatively to record every time they experienced vomiting.</population>
          <units>occurrence of vomiting</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient-Reported Constipation</title>
        <description>Total occurrences of patient-reported constipation post-surgery.</description>
        <time_frame>Post-Surgery (up to 6 days)</time_frame>
        <population>This analysis includes participants completing the study and who used a smartphone application for 6 days post-operatively to record every time they experienced constipation.</population>
        <group_list>
          <group group_id="O1">
            <title>Femoral Nerve Block</title>
            <description>Participants randomized to receive 20mL of ropivacaine 0.5% in the femoral nerve.</description>
          </group>
          <group group_id="O2">
            <title>Adductor Canal Block</title>
            <description>Participants randomized to receive 20mL of ropivacaine 0.5% in the adductor canal</description>
          </group>
        </group_list>
        <measure>
          <title>Patient-Reported Constipation</title>
          <description>Total occurrences of patient-reported constipation post-surgery.</description>
          <population>This analysis includes participants completing the study and who used a smartphone application for 6 days post-operatively to record every time they experienced constipation.</population>
          <units>occurrence of constipation</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient-Reported Sedation</title>
        <description>Total occurrences of patient-reported feelings of sedation post-surgery.</description>
        <time_frame>Post-Surgery (up to 6 days)</time_frame>
        <population>This analysis includes participants who completed the study and used a smartphone application for 6 days post-operatively to record every time they experienced feelings of sedation.</population>
        <group_list>
          <group group_id="O1">
            <title>Femoral Nerve Block</title>
            <description>Participants randomized to receive 20mL of ropivacaine 0.5% in the femoral nerve.</description>
          </group>
          <group group_id="O2">
            <title>Adductor Canal Block</title>
            <description>Participants randomized to receive 20mL of ropivacaine 0.5% in the adductor canal</description>
          </group>
        </group_list>
        <measure>
          <title>Patient-Reported Sedation</title>
          <description>Total occurrences of patient-reported feelings of sedation post-surgery.</description>
          <population>This analysis includes participants who completed the study and used a smartphone application for 6 days post-operatively to record every time they experienced feelings of sedation.</population>
          <units>occurrence of sedation</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient-Reported Itching</title>
        <description>Total occurrences of patient-reported itching post-surgery.</description>
        <time_frame>Post-Surgery (up to 6 days)</time_frame>
        <population>This analysis includes participants who completed the study and used a smartphone application for 6 days post-operatively to record every time they experienced itching.</population>
        <group_list>
          <group group_id="O1">
            <title>Femoral Nerve Block</title>
            <description>Participants randomized to receive 20mL of ropivacaine 0.5% in the femoral nerve.</description>
          </group>
          <group group_id="O2">
            <title>Adductor Canal Block</title>
            <description>Participants randomized to receive 20mL of ropivacaine 0.5% in the adductor canal</description>
          </group>
        </group_list>
        <measure>
          <title>Patient-Reported Itching</title>
          <description>Total occurrences of patient-reported itching post-surgery.</description>
          <population>This analysis includes participants who completed the study and used a smartphone application for 6 days post-operatively to record every time they experienced itching.</population>
          <units>occurrence of itching</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Straight Less Raise</title>
        <description>The amount of time (in hours) it takes for participants to have the ability to perform a straight leg raise post-surgery.</description>
        <time_frame>Post-Surgery (up to 6 days)</time_frame>
        <population>This analysis includes participants who completed the study and used a smartphone application to record when they were able to perform a straight leg raise following surgery.</population>
        <group_list>
          <group group_id="O1">
            <title>Femoral Nerve Block</title>
            <description>Participants randomized to receive 20mL of ropivacaine 0.5% in the femoral nerve.</description>
          </group>
          <group group_id="O2">
            <title>Adductor Canal Block</title>
            <description>Participants randomized to receive 20mL of ropivacaine 0.5% in the adductor canal</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Straight Less Raise</title>
          <description>The amount of time (in hours) it takes for participants to have the ability to perform a straight leg raise post-surgery.</description>
          <population>This analysis includes participants who completed the study and used a smartphone application to record when they were able to perform a straight leg raise following surgery.</population>
          <units>hours</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.7" spread="26.1"/>
                    <measurement group_id="O2" value="16.4" spread="10.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percent of Patients Rating Their Satisfaction as &quot;Excellent&quot; or &quot;Good&quot;</title>
        <description>Patient satisfaction will be reported on a scale of excellent, good, satisfactory, or poor, two weeks following surgery.</description>
        <time_frame>2 Weeks Post-Surgery</time_frame>
        <population>This analysis includes participants who completed the study and used a smartphone application to record study outcome measures following surgery.</population>
        <group_list>
          <group group_id="O1">
            <title>Femoral Nerve Block</title>
            <description>Participants randomized to receive 20mL of ropivacaine 0.5% in the femoral nerve.</description>
          </group>
          <group group_id="O2">
            <title>Adductor Canal Block</title>
            <description>Participants randomized to receive 20mL of ropivacaine 0.5% in the adductor canal</description>
          </group>
        </group_list>
        <measure>
          <title>Percent of Patients Rating Their Satisfaction as &quot;Excellent&quot; or &quot;Good&quot;</title>
          <description>Patient satisfaction will be reported on a scale of excellent, good, satisfactory, or poor, two weeks following surgery.</description>
          <population>This analysis includes participants who completed the study and used a smartphone application to record study outcome measures following surgery.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39"/>
                    <measurement group_id="O2" value="64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Data regarding adverse events were collected from the time a participant gave informed consent to take part in the study until the end of the study follow up.</time_frame>
      <desc>Any change from baseline considered by the investigator to be an untoward medical occurrence different from the standard of care, was reported as an adverse event. Any change from baseline considered by the investigator to be part of the normal daily fluctuations of the underlying disease process, was not reported as an adverse event.</desc>
      <group_list>
        <group group_id="E1">
          <title>Femoral Nerve Block</title>
          <description>Participants randomized to receive 20mL of ropivacaine 0.5% in the femoral nerve.</description>
        </group>
        <group group_id="E2">
          <title>Adductor Canal Block</title>
          <description>Participants randomized to receive 20mL of ropivacaine 0.5% in the adductor canal</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Data collection with a paper journal was low, resulting in the study switching to a smartphone application for participant record keeping. The data analyses include participants who enrolled after the smartphone application became available.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>John Xerogeanes, MD</name_or_title>
      <organization>Emory University</organization>
      <phone>404-778-7202</phone>
      <email>jxeroge@emory.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

